Page last updated: 2024-11-07

penicillamine and Diffuse Parenchymal Lung Disease

penicillamine has been researched along with Diffuse Parenchymal Lung Disease in 3 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mouthon, L1
Berezné, A1
Poiraudeau, S1
Guillevin, L1
Saag, KG1
Kolluri, S1
Koehnke, RK1
Georgou, TA1
Rachow, JW1
Hunninghake, GW1
Schwartz, DA1
Pope, JE1

Reviews

2 reviews available for penicillamine and Diffuse Parenchymal Lung Disease

ArticleYear
[Therapeutic management of systemic sclerosis].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:12 Pt 2

    Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Anti-Inflam

2006
Treatment of systemic sclerosis.
    Rheumatic diseases clinics of North America, 1996, Volume: 22, Issue:4

    Topics: Antirheumatic Agents; Calcinosis; Clinical Trials as Topic; Gastrointestinal Diseases; Heart Disease

1996

Other Studies

1 other study available for penicillamine and Diffuse Parenchymal Lung Disease

ArticleYear
Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities.
    Arthritis and rheumatism, 1996, Volume: 39, Issue:10

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Female; Gold; Humans; Lung Disea

1996